INKT
MiNK Therapeutics, Inc.
-0.12 (-1.03%)11.47USD1.7K成交股數58.5M市值–本益比(近四季)182.9股價營收比+20843.7%營收年增(近四季)2026-11-12下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 73K+439% | 81K+104% | 55K-29% | 348.00-99% | 14K-19% | 40K-63% | 78K-47% | 38K-77% | 17K | 107K | 146K | 168K |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 1.9M | 1.2M | 1.1M | 1.8M | 1.3M | 1.4M | 541K | 1.8M | 2.5M | 3.4M | 4.6M | 4.2M |
| 銷售管理費用 | 1.3M | 1.7M | 1.8M | 1.8M | 1.3M | 809K | 1.2M | 1.1M | 1.3M | 1.8M | 1.8M | 1.7M |
| 營業利益 | −3.2M+19% | −2.9M+15% | −3.2M+69% | −4.1M+32% | −2.7M-29% | −2.5M-52% | −1.9M-70% | −3.1M-48% | −3.8M | −5.2M | −6.3M | −5.9M |
| 營業利益率 | -4,413.7% | -3,565.1% | -5,772.5% | -1,164,481.6% | -19,979.9% | -6,324.0% | -2,415.7% | -8,005.9% | -23,045.4% | -4,868.8% | -4,333.2% | -3,483.4% |
| 稅後淨利 | −3.1M+13% | −2.7M+11% | −2.9M+60% | −4.2M+57% | −2.8M-27% | −2.5M-52% | −1.8M-71% | −2.7M-52% | −3.8M | −5.1M | −6.2M | −5.7M |
| 淨利率 | -4,292.0% | -3,392.6% | -5,236.0% | -1,217,744.5% | -20,468.3% | -6,224.0% | -2,315.7% | -7,043.3% | -22,945.4% | -4,768.8% | -4,233.2% | -3,383.4% |
| 稀釋 EPS | -0.62-11% | -0.570% | -0.65+41% | -1.06+45% | -0.70-36% | -0.57+280% | -0.46+156% | -0.73+329% | -1.10 | -0.15 | -0.18 | -0.17 |
| 稀釋股數 | 5.0M | 4.8M | 4.4M | 4.0M | 4.0M | 3.8M | 4.0M | 3.7M | 3.5M | 34.5M | 34.4M | 34.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 8.8M | 9.5M | 9.5M | 1.7M | 3.2M | 4.6M | 6.3M | 9.3M | 5.8M | 6.4M | 10.6M | 14.9M |
| 應收帳款 | – | – | – | – | – | – | – | – | – | – | – | – |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 9.6M | 10.4M | 15.0M | 2.5M | 4.3M | 5.7M | 7.4M | 10.3M | 6.9M | 7.5M | 12.1M | 16.6M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 股東權益 | −14.0M | −12.7M | −13.5M | −25.2M | −21.8M | −19.6M | −17.6M | −16.6M | −20.3M | −13.6M | −9.5M | −4.5M |
| 負債比 | – | – | – | – | – | – | – | – | – | – | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.7M | – | – | −1.3M-47% | – | – | – | −2.5M | – | – | −4.4M |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | 14K |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | −4.4M |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | -2,606.2% |
營收拆解
這家公司的 XBRL 沒有標分部、產品或地區營收。多半是單一業務,或只在 10-K 文字裡揭露。
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 180K | +4.4% | −12.5M | -6,931.8% | -2.93 | – |
| FY2024 | 173K | -62.7% | −10.8M | -6,249.6% | -2.86 | – |
| FY2023 | 463K | +82.9% | −22.5M | -4,847.8% | -6.54 | −15.8M |
| FY2022 | 253K | -110.4% | −28.0M | -11,049.6% | -0.83 | −19.1M |
| FY2021 | −2.4M | – | −30.2M | 1,242.5% | -1.16 | −13.1M |
| FY2020 | – | – | −16.2M | –% | -0.67 | −8.4M |